PT917581E - Polipéptidos de fusão compreendendo um domínio de ligação a ige e um componente hsa e sua utilização em diagnóstico e terapêutica - Google Patents

Polipéptidos de fusão compreendendo um domínio de ligação a ige e um componente hsa e sua utilização em diagnóstico e terapêutica Download PDF

Info

Publication number
PT917581E
PT917581E PT97940030T PT97940030T PT917581E PT 917581 E PT917581 E PT 917581E PT 97940030 T PT97940030 T PT 97940030T PT 97940030 T PT97940030 T PT 97940030T PT 917581 E PT917581 E PT 917581E
Authority
PT
Portugal
Prior art keywords
ige
diagnostic
binding domain
fusion polypeptides
therapeutic uses
Prior art date
Application number
PT97940030T
Other languages
English (en)
Inventor
Hermann Gram
Mary Ellen Digan
Philip Lake
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT917581E publication Critical patent/PT917581E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT97940030T 1996-07-26 1997-07-25 Polipéptidos de fusão compreendendo um domínio de ligação a ige e um componente hsa e sua utilização em diagnóstico e terapêutica PT917581E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69021696A 1996-07-26 1996-07-26

Publications (1)

Publication Number Publication Date
PT917581E true PT917581E (pt) 2008-04-11

Family

ID=24771594

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97940030T PT917581E (pt) 1996-07-26 1997-07-25 Polipéptidos de fusão compreendendo um domínio de ligação a ige e um componente hsa e sua utilização em diagnóstico e terapêutica

Country Status (28)

Country Link
EP (1) EP0917581B1 (pt)
JP (1) JP3681402B2 (pt)
KR (1) KR100502879B1 (pt)
CN (1) CN1146664C (pt)
AR (1) AR008077A1 (pt)
AT (1) ATE383429T1 (pt)
AU (1) AU722069B2 (pt)
BR (1) BR9710605A (pt)
CA (1) CA2261562C (pt)
CO (1) CO4650184A1 (pt)
CZ (1) CZ297634B6 (pt)
DE (1) DE69738452T2 (pt)
ES (1) ES2300114T3 (pt)
HK (1) HK1020352A1 (pt)
ID (1) ID19420A (pt)
IL (2) IL128094A0 (pt)
MY (1) MY120425A (pt)
NO (1) NO323611B1 (pt)
NZ (1) NZ333908A (pt)
PE (1) PE99498A1 (pt)
PL (1) PL189415B1 (pt)
PT (1) PT917581E (pt)
RU (1) RU2209211C2 (pt)
SK (1) SK7799A3 (pt)
TR (1) TR199900155T2 (pt)
TW (1) TW565571B (pt)
WO (1) WO1998004718A1 (pt)
ZA (1) ZA976666B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056471A4 (en) * 1998-01-29 2001-05-30 Tanox Inc TREATMENT OF ATOPIC DERMATITIS USING IgE ANTAGONISTS
JP4087563B2 (ja) 1998-06-15 2008-05-21 ジーティーシー バイオセラピューティックス インコーポレイテッド エリスロポエチン類似体−ヒト血清アルブミン融合物
EP1208194A2 (en) * 1999-08-09 2002-05-29 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
DE10026998A1 (de) * 2000-05-31 2001-12-13 Fresenius Kabi De Gmbh Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde
IL155812A0 (en) * 2000-12-07 2003-12-23 Lilly Co Eli Glp-1 fusion proteins
TW200526779A (en) * 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
EP1463751B1 (en) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albumin fusion proteins
US8927694B2 (en) 2008-11-18 2015-01-06 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
US8962274B2 (en) 2009-02-27 2015-02-24 Novartis Ag Methods for selecting eukaryotic cells expressing a heterologous protein
WO2012169735A2 (ko) * 2011-06-07 2012-12-13 (주)네오팜 FCεRI의 수용성 단편을 포함하는 복합체 및 이를 포함하는 IGE 매개 알레르기성 질환 치료용 조성물
RU2506271C2 (ru) * 2011-06-22 2014-02-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД А2, СЕЛЕКТИВНО СВЯЗЫВАЮЩИЙ HSA, РЕКОМБИНАНТНАЯ ДНК pa2, КОДИРУЮЩАЯ HSA-СВЯЗЫВАЮЩУЮ ЧАСТЬ ПОЛИПЕПТИДА A2, ЕГО ПРОДУЦЕНТ - РЕКОМБИНАНТНЫЙ ШТАММ Escherichia coli M15-A2, СОДЕРЖАЩИЙ РЕКОМБИНАНТНУЮ ПЛАЗМИДНУЮ ДНК pQE 32-pa2, ОБЕСПЕЧИВАЮЩУЮ ПОЛУЧЕНИЕ ПОЛИПЕПТИДА A2 И ПРИМЕНЕНИЕ ПОЛИПЕПТИДА А2 ДЛЯ ДИАГНОСТИКИ МИКРОАЛЬБУМИНУРИИ И ВЫДЕЛЕНИЯ HSA ИЗ СЫВОРОТКИ КРОВИ
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
US20180139938A1 (en) * 2015-05-04 2018-05-24 Laboratoire Français du Fractionnement et des, Biotechnologies Transgenic production of fc fusion proteins
EP3192806A1 (en) 2016-01-13 2017-07-19 Affiris AG Alpha chain of the high-affinity ige receptor (fceria)
JP7127859B2 (ja) * 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
EP3998277A4 (en) * 2019-07-08 2023-11-22 Progen Co., Ltd. NOVEL IL-10 PROTEIN VARIANT AND THEREOF USE
CN111773392B (zh) * 2020-05-25 2023-04-07 河南省生物工程技术研究中心 一种人血白蛋白/寡核苷酸纳米颗粒及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
GB8909916D0 (en) * 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies

Also Published As

Publication number Publication date
KR100502879B1 (ko) 2005-07-25
DE69738452T2 (de) 2008-12-24
KR20000029563A (ko) 2000-05-25
AR008077A1 (es) 1999-12-09
EP0917581B1 (en) 2008-01-09
MY120425A (en) 2005-10-31
HK1020352A1 (en) 2000-04-14
IL128094A (en) 2006-08-20
WO1998004718A1 (en) 1998-02-05
NO323611B1 (no) 2007-06-18
BR9710605A (pt) 1999-08-17
CO4650184A1 (es) 1998-09-03
ES2300114T3 (es) 2008-06-01
JP2000516089A (ja) 2000-12-05
ZA976666B (en) 1999-01-25
TW565571B (en) 2003-12-11
JP3681402B2 (ja) 2005-08-10
PE99498A1 (es) 1999-01-21
EP0917581A1 (en) 1999-05-26
ATE383429T1 (de) 2008-01-15
CZ24699A3 (cs) 1999-04-14
IL128094A0 (en) 1999-11-30
CN1229439A (zh) 1999-09-22
AU722069B2 (en) 2000-07-20
CA2261562C (en) 2011-04-05
DE69738452D1 (de) 2008-02-21
PL331356A1 (en) 1999-07-05
NZ333908A (en) 1999-10-28
TR199900155T2 (xx) 2000-08-21
AU4202597A (en) 1998-02-20
NO990328D0 (no) 1999-01-25
CN1146664C (zh) 2004-04-21
RU2209211C2 (ru) 2003-07-27
ID19420A (id) 1998-07-09
NO990328L (no) 1999-02-19
SK7799A3 (en) 1999-07-12
PL189415B1 (pl) 2005-08-31
CA2261562A1 (en) 1998-02-05
CZ297634B6 (cs) 2007-02-21

Similar Documents

Publication Publication Date Title
PT917581E (pt) Polipéptidos de fusão compreendendo um domínio de ligação a ige e um componente hsa e sua utilização em diagnóstico e terapêutica
EP0894807A4 (en) GPIb lipid complex and its applications
SG77133A1 (en) Method for hair joining and hair-joining device used for the same
AU2527397A (en) Fas ligand fusion proteins and their uses
IL127756A0 (en) Tubular switch and device for connecting the switch
HUP9602675A2 (en) Multilayer wrapring-foil based on polypropylene and using thereof
IL127735A0 (en) Medical device
GB2304309B (en) Laminate and use thereof
GB9702181D0 (en) Composite component
GB9617034D0 (en) Medical cryo-surgical device
EP0973478A4 (en) PASSIVE JOINT MOVEMENT DEVICE AND METHOD FOR USE THEREOF
AU3305197A (en) Non-activated receptor complex proteins and uses thereof
GB9609339D0 (en) Device and assembly
EP1027098A4 (en) ELECTRICALLY ACTIVATED SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
AU3116697A (en) Human interleukin-1j and antagonists thereof
GB2317113B (en) Skin allergy test assembly
HUP9903094A3 (en) Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
IL103730A0 (en) Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding
AUPM731394A0 (en) Improved activated protein c resistance test
AU3502997A (en) Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof
AU3628697A (en) Lipid-binding proteins and their therapeutic and diagnostic use
HUP9904273A3 (en) Drug resistance and multidrug resistance modulators
GB2321558B (en) Chip resistor and method for producing the same
GB9615924D0 (en) Medical device
IL119066A0 (en) Transmembrane movement and multidrug resistance